A2 Biotherapeutics emerges from Stealth Mode to develop tumour cell therapeutics

This article was originally published here

The company, founded in 2018 by veteran biotechnology leaders, has a unique and potentially broad solution for the central problem of cancer research – targeted killing of tumor

The post A2 Biotherapeutics emerges from Stealth Mode to develop tumour cell therapeutics appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply